The U.S. Supreme Court said Monday that it declined to review a challenge to an appeals court decision upholding a $114 million verdict finding that the co-owner of a marketing firm and others engaged in a blood test kickback scheme to defraud Medicare.
The government convinced a jury that two laboratory companies paid commissions to Floyd Calhoun Dent III’s marketing firm Bluewave Healthcare Consultants Inc. based on blood-test sales numbers and that this violated the Anti-Kickback Statute.
The U.S. Court of Appeals for the Fourth Circuit affirmed the award, ruling that Dent and others knowingly made unlawful payments to salespeople ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.